Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Cartesian Therapeutics Inc (RNAC)

Cartesian Therapeutics Inc (RNAC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
11.83 -0.22 (-1.83%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 11.83 unch (unch) 16:02 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Cartesian Therapeutics Inc 7495 New Horizon Way Frederick MD 21703 USA

www.cartesiantherapeutics.com Employees: 66 P: 301-348-8698

Sector:

Medical

Description:

Cartesian Therapeutics is a clinical-stage company pioneering RNA cell therapies for the treatment of autoimmune diseases. The company's lead asset, Descartes-08, is a potential first-in-class, RNA-engineered chimeric antigen receptor T-cell therapy in Phase 2b clinical development for patients with generalized myasthenia gravis. Cartesian Therapeutics, formerly known as Selecta Biosciences Inc., is based in WATERTOWN, Mass.

Key Statistics

Overview:

Market Capitalization, $K 306,480
Enterprise Value, $K 93,870
Shares Outstanding, K 25,907
Annual Sales, $ 38,910 K
Annual Net Income, $ -77,420 K
Last Quarter Sales, $ 390 K
Last Quarter Net Income, $ -24,180 K
EBIT, $ -53,500 K
EBITDA, $ -52,350 K
60-Month Beta 0.55
% of Insider Shareholders 57.90%
% of Institutional Shareholders 86.95%
Float, K 10,907
% Float 42.10%
Short Volume Ratio 0.84

Growth:

1-Year Return -43.40%
3-Year Return -48.54%
5-Year Return -84.83%
5-Year Revenue Growth 482.49%
5-Year Earnings Growth 87.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.69 on 11/07/24
Next Earnings Date 05/14/25 [--]
Earnings Per Share ttm -4.52
EPS Growth vs. Prev Qtr -227.78%
EPS Growth vs. Prev Year -77.97%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 04/05/24

RNAC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -5.58%
Profit Margin % -198.97%
Debt/Equity 0.00
Price/Sales 8.02
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.04
Interest Coverage -1.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective